ADVERTISEMENT
Manila Bulletin devider Philippines devider 45 immunocompromised people get second booster shot in Muntinlupa

45 immunocompromised people get second booster shot in Muntinlupa

Published Apr 28, 2022 03:49 pm

A total of 45 immunocompromised people, or those with weakened immune system, have received their second booster shot in Muntinlupa.

The Muntinlupa City government started administering the second booster shot for immunocompromised people on April 26.

Vaccination in Muntinlupa (Photo from Muntinlupa PIO)

In two days, 45 people belonging to the group got their booster shots in the city, 14 of them on the first day on April 26 and 31 on the second day on April 27.

Of the 45, 13 are from Barangay Putatan, seven each from Barangays Ayala Alabang, Cupang and Tunasan, five from Alabang, three from Poblacion, two in Sucat, and one unclassified.

There are about 10,000 people listed as immunocompromised in the country, said National Task Force Against Covid-19 Medical Adviser Dr. Ted Herbosa during the “Laging Handa" public briefing on April 27.

He said less than 1,000 immunocompromised individuals have received the second booster shot in the country.

The Department of Health (DOH) announced that immunocompromised individuals will be the first to get the second booster shot to be followed by frontline healthcare workers and senior citizens.

“People who are immunocompromised have a reduced ability to fight infections and other diseases,” according to the US National Cancer Institute.

Under a DOH memorandum, immunocompromised individuals are classified as those with immunodeficiency state, HIV, active cancer or malignancy, transplant recipients, undergoing steroid treatment, patients with poor prognosis / bed-ridden patients, and other conditions of immunodeficiency as certified by a doctor.

The vaccine brands to be used for the second booster shot are Pfizer, Moderna, Sinovac, Sinopharm and AstraZeneca.

Herbosa said within the week, the Vaccine Expert Panel will approve the giving of the second booster shot to the A1 priority group (healthcare workers) and A2 (senior citizens).

In Muntinlupa, 493,089 people have been fully vaccinated as of April 27, or 111.43 percent of the target population of 442,517, equivalent to 80 percent of the total population of 553,146.

Of the total fully vaccinated, 128,807 have received their first booster shot or 26 percent.

In addition, 39,405 minors aged 12 to 17 are now fully vaccinated, or 69.74 percent of the total population of 56,499.

Among the five to 11 age group, 12,693 are now fully vaccinated, or 18.61 percent of the total population of 68,198.

Related Tags

second booster shot immunocompromised individuals Muntinlupa 2nd booster shot doh
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.